Literature DB >> 8849146

Withdrawing life support from mechanically ventilated recipients of bone marrow transplants: a case for evidence-based guidelines.

G D Rubenfeld1, S W Crawford.   

Abstract

BACKGROUND: Mechanical ventilation after bone marrow transplantation is associated with a high mortality rate. The available literature provides conflicting predictors of outcome in relatively small study groups.
OBJECTIVE: To identify predictors of death and mortality trends in mechanically ventilated transplant recipients.
DESIGN: Nested case-control study.
SETTING: The Fred Hutchinson Cancer Research Center in Seattle, Washington, which specializes in bone marrow transplantation. PATIENTS: All survivors (cases, n = 53) and a group of patients matched for year of transplantation who did not survive (controls, n = 106) were selected from all mechanically ventilated patients (n = 865) who received a bone marrow transplant between January 1980 and July 1992. Patients who received mechanical ventilation for less than 24 hours after a procedure or who received mechanical ventilation after a second bone marrow transplantation were excluded. MEASUREMENTS: Surviving patients were defined as those who were alive 30 days after extubation and who were discharged from the hospital. Daily laboratory, physiologic, and treatment variables were collected.
RESULTS: Survival was statistically associated with younger age, lower score on the Acute Physiology and Chronic Health Evaluation III, and a shorter time from transplantation to intubation. There were no survivors among an estimated 398 patients who had lung injury and either required more than 4 hours of vasopressor support or had sustained hepatic and renal failure. Through the use of these factors, an accurate prediction of death could have been made in the first 4 days of mechanical ventilation for more than half of the patients who did not survive. During the past 5 years, survival rate has changed from 5% to 16% (P = 0.008), an increase that was not explained by changes in the age of the patients, the rate or timing of intubation, or the percentage of allogeneic transplants that were not HLA-identical.
CONCLUSION: Of the patients who required mechanical ventilation after bone marrow transplantation, no one survived with lung injury combined with either hemodynamic instability or hepatic and renal failure. However, survival after mechanical ventilation seems to be improving.

Entities:  

Keywords:  Death and Euthanasia; Empirical Approach; Fred Hutchinson Cancer Research Center; Professional Patient Relationship

Mesh:

Year:  1996        PMID: 8849146     DOI: 10.7326/0003-4819-125-8-199610150-00001

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  40 in total

1.  Successful allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia during respiratory failure and invasive mechanical ventilation.

Authors:  Alexandra Boehm; Werner Rabitsch; Gottfried J Locker; Nina Worel; Oliver Robak; Klaus F Laczika; Thomas Staudinger; Andja Bojic; Viktoria Siersch; Peter Valent; Wolfgang R Sperr
Journal:  Wien Klin Wochenschr       Date:  2011-06-03       Impact factor: 1.704

2.  The intensive care support of patients with malignancy: do everything that can be done.

Authors:  Elie Azoulay; Bekele Afessa
Journal:  Intensive Care Med       Date:  2005-11-25       Impact factor: 17.440

Review 3.  Diagnostic strategy in cancer patients with acute respiratory failure.

Authors:  Elie Azoulay; Benoît Schlemmer
Journal:  Intensive Care Med       Date:  2006-04-29       Impact factor: 17.440

Review 4.  The pressure to withhold or withdraw life-sustaining therapy from critically ill patients in the United States.

Authors:  John M Luce; Douglas B White
Journal:  Am J Respir Crit Care Med       Date:  2007-03-22       Impact factor: 21.405

5.  What medical futility means to clinicians.

Authors:  Mark R Tonelli
Journal:  HEC Forum       Date:  2007-03

6.  Outcome in severely ill patients with hematological malignancies who received intravenous chemotherapy in the intensive care unit.

Authors:  Dominique D Benoit; Pieter O Depuydt; Koenraad H Vandewoude; Fritz C Offner; Tom Boterberg; Carole A De Cock; Lucien A Noens; Ann M Janssens; Johan M Decruyenaere
Journal:  Intensive Care Med       Date:  2005-11-25       Impact factor: 17.440

7.  The role of futility judgments in improperly limiting the scope of clinical research.

Authors:  W Harper
Journal:  J Med Ethics       Date:  1998-10       Impact factor: 2.903

8.  Engraftment syndrome and survival after respiratory failure post-bone marrow transplantation.

Authors:  D Marín; J Berrade; C Ferra; A Mateu; J Berlanga; A Salar; H Torrado; A Grañena; J L Ventura
Journal:  Intensive Care Med       Date:  1998-07       Impact factor: 17.440

9.  Risk factors for acute respiratory distress syndrome during neutropenia recovery in patients with hematologic malignancies.

Authors:  Chin Kook Rhee; Ji Young Kang; Yong Hyun Kim; Jin Woo Kim; Hyung Kyu Yoon; Seok Chan Kim; Soon Suk Kwon; Young Kyoon Kim; Kwan Hyung Kim; Hwa Sik Moon; Sung Hak Park; Hee Je Kim; Seok Lee; Jeong Sup Song
Journal:  Crit Care       Date:  2009-11-03       Impact factor: 9.097

10.  Admission factors associated with hospital mortality in patients with haematological malignancy admitted to UK adult, general critical care units: a secondary analysis of the ICNARC Case Mix Programme Database.

Authors:  Peter A Hampshire; Catherine A Welch; Lawrence A McCrossan; Katharine Francis; David A Harrison
Journal:  Crit Care       Date:  2009-08-25       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.